News Articles for OncoSil Medical

SPECIAL REPORT: Despite WA's history of innovative medical research, the state's medtech sector continues to grapple with outsider perceptions and its own commercial direction.

FEATURE: Biotech and IT companies are enjoying renewed investor interest, but these innovative businesses are facing a changing capital raising market featuring less government support and, in Perth, a drastic shift in the venture capital sector.

SPECIAL REPORT: The biotech sector came to life in 2013 but pricing was critical to the success or failure of capital raisings.

Consegna Group chairman Martin Rogers has joined NeuroDiscovery as deputy chairman. Mr Rogers is a current non-executive director and former chief executive of Prima BioMed.

Perth-based biotech company NeuroDiscovery is taking a punt on radiotherapy technology being developed in the United Kingdom.

Perth-based neurology focused research and development company NeuroDiscovery has entered a specialist services deal with a major international pharmaceutical company, valued at $620,000, the company's largest every contract.

Perth-based research and development company NeuroDiscovery Ltd is set to launch two clinical trials on new chronic pain relievers.

Perth-based neurology research company NeuroDiscovery Ltd will seek approval from the British Medicines and Healthcare products Regulatory Agency to extend trials of neuropathic pain treatment NSL-043 to higher doses, after the first phase of trials was c

Two Perth-based companies have announced successful captial raising to boost their working capital funds.

Perth-based neurology research company NeuroDiscovery Ltd has announced plans to raise $3.2 million through a share issue and share purchase plan to fund further human trials of its pain-treatment drugs.

1,350,000 fully paid ordinary shares will be released from escrow on 20 April 2006

NeuroDiscovery Ltd 15-Aug-05 David Spanswick became a substantial shareholder with a relevant interest of 2,389,495 ordinary shares (6.55%).

NeuroDiscovery Ltd 15-Aug-05 Fei Yue Zhao became a substantial shareholder with a relevant interest of 2,389,495 ordinary shares (6.55%).

NeuroDiscovery Ltd 15-Aug-05 Kevin Lee became a substantial shareholder with a relevant interest of 2,389,495 ordinary shares (6.55%).

NeuroDiscovery Ltd 15-Aug-05 Margaret Livingston became a substantial shareholder with a relevant interest of 2,375,000 ordinary shares (6.61%).

NeuroDiscovery Ltd 15-Aug-05 Sartino Di Giacomo became a substantial shareholder with a relevant interest of 1,875,000 ordinary shares (6.14%).

NeuroDiscovery Ltd 15-Aug-05 Mark Treherne became a substantial shareholder with a relevant interest of 2,389,495 ordinary shares.